Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Apr 27, 2023; 15(4): 664-673
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.664
Table 3 Computed tomography perfusion comparisons between clinically significant portal hypertension and non-clinically significant portal hypertension before and after transjugular intrahepatic portosystemic shunt
Parameters
NCSPH (n = 11)
CSPH (n = 13)
P value
Before TIPS
Liver parenchyma
LBF103.6 ± 23.391.7 ± 38.30.377
LBV19.5 ± 2.918.9 ± 6.90.796
HAF (× 10-2)5.4 ± 2.818.2 ± 10.90.001
Spleen parenchyma
SBF95.9 ± 25.1117.4 ± 34.90.102
SBV12.4 ± 3.512.0 ± 2.70.747
After TIPS
Liver parenchyma
LBF77.5 ± 33.992.8 ± 41.00.336
LBV11.3 ± 2.412.7 ± 2.20.165
HAF (× 10-2)54.4 ± 11.456.0 ± 8.80.711
Spleen parenchyma
SBF150.0 ± 35.7169.9 ± 29.10.153
SBV19.2 ± 3.818.3 ± 3.00.522